IMNM
Immunome Inc
NASDAQ: IMNM · HEALTHCARE · BIOTECHNOLOGY
$22.95
-3.21% today
Updated 2026-04-29
Market cap
$2.60B
P/E ratio
—
P/S ratio
374.45x
EPS (TTM)
$-2.43
Dividend yield
—
52W range
$7 – $28
Volume
1.2M
Immunome Inc (IMNM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $6.63M | $14.02M | $9.04M | $6.94M |
| Revenue growth (YoY) | — | — | — | — | — | +111.5% | -35.5% | -23.2% |
| Cost of revenue | $521000.00 | $615000.00 | $755000.00 | $755000.00 | $631000.00 | $728000.00 | $2.10M | $2.96M |
| Gross profit | $-521000.00 | $-615000.00 | $-755000.00 | $-755000.00 | $-631000.00 | $14.02M | $9.04M | $3.99M |
| Gross margin | — | — | — | — | -9.5% | 100.0% | 100.0% | 57.4% |
| R&D | $6.88M | $8.82M | $7.49M | $14.11M | $23.27M | $23.09M | $129.54M | $174.33M |
| SG&A | $866000.00 | $1.52M | $4.78M | $11.09M | $13.63M | $19.66M | $32.95M | $43.77M |
| Operating income | $-7.74M | $-10.35M | $-12.26M | $-25.20M | $-36.90M | $-109.53M | $-305.80M | $-214.11M |
| Operating margin | — | — | — | — | -556.8% | -781.4% | -3382.4% | -3084.8% |
| EBITDA | $-7.18M | $-9.72M | $-11.51M | $-24.45M | $-36.27M | $-28.00M | $-151.35M | $-211.16M |
| EBITDA margin | — | — | — | — | -547.3% | -199.7% | -1674.1% | -3042.2% |
| EBIT | $-7.70M | $-10.34M | $-12.26M | $-25.20M | $-36.90M | $-28.73M | $-153.46M | $-214.11M |
| Interest expense | $141000.00 | $106000.00 | $38000.00 | $10000.00 | $5000.00 | — | — | — |
| Income tax | $39000.00 | $106000.00 | $-717000.00 | $-242000.00 | $617000.00 | $560105.00 | $-292.96M | — |
| Effective tax rate | -0.5% | -1.0% | 4.0% | 1.0% | -1.7% | -0.5% | 50.0% | 0.0% |
| Net income | $-7.84M | $-10.55M | $-17.12M | $-24.71M | $-36.90M | $-106.81M | $-292.96M | $-212.39M |
| Net income growth (YoY) | — | -34.5% | -62.3% | -44.3% | -49.3% | -189.5% | -174.3% | +27.5% |
| Profit margin | — | — | — | — | -556.8% | -761.9% | -3240.4% | -3060.0% |